Answers are grounded in this paper and cite their sources.
Natural clearance of hepatitis C virus (HCV) infection occurs in about 25% of primary infections, but offers only partial protective immunity against re‐infections. This study hypothesised that long‐lived polyfunctional HCV‐specific CD8+ memory stem T cells (T SCM ) contribute to protective immunity in rare super‐clearer subjects who repeatedly clear viraemia. Six super‐clearers and four clearer‐chronic subjects who resolved a primary infection but subsequently developed chronic infection were studied at multiple timepoints. The T SCM population (CCR7+CD45RA+CD95+) was bulk sorted, labelled with CellTrace Violet (CTV), and stimulated in vitro for five days with cognate HCV peptide, IL‐2/IL‐15, and autologous PBMCs. Functionality of the expanded HCV‐specific T SCM was assessed via the proliferation, multi‐potency, and stemness indices. Total HCV‐specific CD8+ T cells from super‐clearers exhibited enhanced proliferative recall capability compared with clearer‐chronics. Furthermore, super‐clearers exhibited higher HCV‐T SCM frequencies post‐expansion (22.35 ± 34.35 vs. 2.41 ± 9.83; p = 0.0066). Notably, HCV‐T SCM in clearer‐chronics had ‘stemness’ indices of zero in samples before the re‐infection (i.e., no ability to generate T SCM as progeny), whereas super‐clearers consistently retained this key functional property. These findings suggest that the maintenance of self‐renewing HCV‐specific T SCM may underpin long‐term protective immunity against re‐infection and could inform vaccine design strategies targeting durable cellular memory.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: